Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ER Niacin/Laropiprant in Patients with Type 2 Diabetes Mellitus
2007-002515-75Phase 4Completed
- Sponsor
- MSD
- Start
- Jun 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in type 2 diabetes mellitus (T2DM) and hypercholesterolemia comparing ER niacin/laropiprant with Placebo (2 arms). Primary endpoint: Percent change from baseline in LDL-C at Week 12. Started Jun 2007; status: completed.
02
Drugs
laropiprant + niacin
03
Conditions
type 2 diabetes mellitus (T2DM)hypercholesterolemia
Beyond the preview
Go deeper on 2007-002515-75.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-002515-75.